Transthyretin-mediated Amyloidosis (ATTR Amyloidosis)
1 clinical trials · Condition
◉ Watch Transthyretin-mediated Amyloidosis (ATTR Amyloidosis)
| Record | Firm | Date |
|---|---|---|
| A Safety and Tolerability Study of an Investigational Drug, ALN-TTRSC02, in Healthy Subjects (NCT02797847) | Alnylam Pharmaceuticals | 2016-06-07 |
Track Transthyretin-mediated Amyloidosis (ATTR Amyloidosis) automatically
Every clearance here is in the API, with alerts when new ones post.